{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:21:57Z","timestamp":1785831717079,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ijantimicag.2008.03.014","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T08:23:26Z","timestamp":1214036606000},"page":"145-153","source":"Crossref","is-referenced-by-count":36,"title":["Oral levofloxacin 500mg once daily in the treatment of chronic bacterial prostatitis"],"prefix":"10.1016","volume":"32","author":[{"given":"K.G.","family":"Naber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Roscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.03.014_bib1","first-page":"5","article-title":"The impact of acute or chronic inflammation in baseline biopsy on the risk of progression in the MTOPS study","volume":"3","author":"Roehrborn","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib3","first-page":"1","article-title":"Diagnosing prostatitis: a clinical dilemma","author":"Krieger","year":"1998","journal-title":"Patient Care"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib4","first-page":"492","article-title":"Bacteriologic localization patterns in bacterial prostatitis and urethritis","volume":"5","author":"Meares","year":"1968","journal-title":"Invest Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib5","series-title":"Infectious diseases","first-page":"467","article-title":"Bacterial prostatitis and recurrent urinary tract infections","author":"Meares","year":"1972"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib6","first-page":"38","article-title":"The pre and post massage test (PPMT): a simple screen for prostatitis","volume":"3","author":"Nickel","year":"1997","journal-title":"Techniques Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-5347(06)00498-8","article-title":"How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis\/chronic pelvic pain syndrome?","volume":"176","author":"Nickel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/28.suppl_C.87","article-title":"An assessment of temafloxacin in the treatment of chronic bacterial prostatitis","volume":"28","author":"Naber","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib9","doi-asserted-by":"crossref","first-page":"134S","DOI":"10.1016\/0002-9343(91)90326-S","article-title":"Treatment of chronic bacterial prostatitis with temafloxacin","volume":"91","author":"Cox","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(99)00142-9","article-title":"Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up","volume":"14","author":"Naber","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0924-8579(02)00067-5","article-title":"Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis","volume":"20","author":"Naber","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-5347(17)60034-X","article-title":"Trimethoprim sulfamethoxazole therapy of chronic bacterial prostatitis","volume":"111","author":"Drach","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-5347(17)52906-7","article-title":"A study of the effectiveness of rifaprim in chronic prostatitis caused mainly by Staphylococcus aureus","volume":"128","author":"Giamarellou","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-5347(17)37247-6","article-title":"Coagulase-negative staphylococcus in chronic prostatitis","volume":"147","author":"Nickel","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib16","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/JCM.37.6.1863-1870.1999","article-title":"Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and \u2018nonbacterial\u2019 prostatitis","volume":"37","author":"Tanner","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.urology.2005.04.065","article-title":"Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis","volume":"66","author":"Krieger","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib18","first-page":"427","article-title":"Proposal of a standard method for clinical evaluation of antimicrobial agents in prostatitis. Specification of patients and criteria for evaluation of clinical efficacy","volume":"35","author":"Kamidono","year":"1989","journal-title":"Acta Urol Jpn"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib19","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.8.11.1667","article-title":"Therapy for prostatitis, with emphasis on bacterial prostatitis","volume":"8","author":"Wagenlehner","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2006.07.026","article-title":"Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose","volume":"28","author":"Wagenlehner","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib22","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/AAC.00477-06","article-title":"Urinary bactericidal activity of extended-release ciprofloxacin (1 000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose","volume":"50","author":"Wagenlehner","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib23","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib24","series-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Limitations in the use of drug cocktails (DC) to compare the pharmacokinetics (PK) of drugs: ciprofloxacin (CIP) vs. levofloxacin (LEV)","author":"Bulitta","year":"2000"},{"key":"10.1016\/j.ijantimicag.2008.03.014_bib25","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1007\/BF01643681","article-title":"Rat model of experimental bacterial prostatitis","volume":"19","author":"Nickel","year":"1991","journal-title":"Infection"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T14:12:09Z","timestamp":1588774329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0924857908001489"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.03.014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}